Michael Zdanowski
Corporate Officer/Principal chez Medeor Therapeutics, Inc.
Fortune : 2 352 $ au 30/04/2024
Postes actifs de Michael Zdanowski
Sociétés | Poste | Début | Fin |
---|---|---|---|
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - | - |
New York Stem Cell Foundation, Inc. | Corporate Officer/Principal | - | - |
Historique de carrière de Michael Zdanowski
Anciens postes connus de Michael Zdanowski
Sociétés | Poste | Début | Fin |
---|---|---|---|
TOURMALINE BIO, INC. | Directeur Technique/Scientifique/R&D | 01/10/2020 | 28/04/2023 |
Formation de Michael Zdanowski
Columbia University School of the Arts | Masters Business Admin |
University of Pennsylvania | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 6 |
Opérationnelle
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Masters Business Admin | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Health Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. Medical/Nursing ServicesHealth Services Medeor Therapeutics, Inc. engages in medical industry. It provides services which are dedicated to the discovery, development, and commercialization of transformative and personalized cellular therapeutics. The company was founded by Samuel Strober, Edgar Engleman, Robert Lowsky, and Chih Ping in 2012 and is headquartered in South San Francisco, CA. | Health Services |
New York Stem Cell Foundation, Inc. | Miscellaneous |
- Bourse
- Insiders
- Michael Zdanowski
- Expérience